10-Q: 180 Life Sciences Corp. Reports Q3 2024 Results, Announces Strategic Shift to iGaming

180 Life Sciences Corp. reports a net loss for Q3 2024 but highlights a strategic move into the iGaming industry with the acquisition of a blockchain casino platform.

Summary

• 180 Life Sciences Corp. reported a net loss of $836,720 for the three months ended September 30, 2024, and a net loss of $1,894,683 for the nine months ended September 30, 2024.
• The company's operating expenses decreased significantly compared to the same periods in 2023, primarily due to reduced research and development spending and lower general and administrative costs.
• 180 Life Sciences acquired source code and intellectual property for an online blockchain casino for $7,622,041, signaling a strategic shift into the iGaming sector.
• The company is planning to launch a B2C online casino operation and explore B2B opportunities, with a target launch date for the first online casino by the end of Q1 2025.
• The company is subject to a mandatory panel monitor for one year from October 4, 2024, due to non-compliance with Nasdaq's continued listing rules, but has regained compliance with the Equity Rule.
• The company has a working capital deficit of $5,158,449 as of September 30, 2024, and expects to require significant additional capital to fund its operations and new iGaming venture.
• The company has a going concern warning and expects to need to raise additional capital to fund operations.

Sentiment

Score: 5

Explanation: The document presents a mixed picture. While the company has made a strategic move into iGaming and reduced its losses, it faces significant financial challenges, including a going concern warning and the need for substantial additional capital. The company also faces significant risks in the new iGaming venture and has compliance issues with Nasdaq.

Positives

• The company's net loss decreased significantly in Q3 2024 compared to Q3 2023.
• Operating expenses, including research and development and general and administrative costs, decreased substantially in Q3 2024 compared to Q3 2023.
• The company has made a strategic move into the iGaming industry with the acquisition of a blockchain casino platform.
• The company received $3,320,331 in cash from the exercise of warrants in October 2024.
• The company has regained compliance with Nasdaq's Equity Rule.

Negatives

• The company reported a net loss of $836,720 for Q3 2024 and $1,894,683 for the nine months ended September 30, 2024.
• The company has a working capital deficit of $5,158,449 as of September 30, 2024.
• The company has a going concern warning and expects to need to raise additional capital to fund operations.
• The company is subject to a mandatory panel monitor for one year from October 4, 2024, due to non-compliance with Nasdaq's continued listing rules.
• The company has no operating history in the gaming industry and may not be successful in this endeavor.

Risks

• The company needs to raise significant additional capital to fund its operations and new iGaming venture.
• The company has a going concern warning and may not be able to continue as a going concern.
• The company is subject to a mandatory panel monitor for one year from October 4, 2024, due to non-compliance with Nasdaq's continued listing rules.
• The company has no operating history in the gaming industry and may not be successful in this endeavor.
• The company faces significant competition in the online gaming industry.
• The company's license agreements with the University of Oxford may be terminated in certain circumstances.
• The company may not receive any further amount under its pre-merger directors and officers insurance policy in connection with certain litigation matters.
• The company may be subject to litigation and damages for its failure to pay amounts due to the University of Oxford.
• The company faces cyber security risks that could result in damage to the company's reputation and/or subject them to fines, payment of damages, lawsuits and restrictions on the company's use of data.
• The company's planned online casino is part of a new and evolving industry, which presents significant uncertainty and business risks.
• The company may be unable to obtain or maintain all necessary registrations, licenses, permits or approvals, and could incur fines or experience delays related to the licensing process.
• The company's future gaming licenses could be revoked, suspended or conditioned at any time.
• The company's product offerings must be approved in most regulated jurisdictions in which they are offered; this process cannot be assured or guaranteed.
• Legislative and regulatory changes could negatively affect the business of the company and the business of its customers.
• A reduction in discretionary consumer spending, from an economic downturn or disruption of financial markets or other factors, could negatively impact the financial performance of the company as it develops its iGaming business.
• The company's common stock is subject to an illiquid and volatile market.
• The company's outstanding public warrants are significantly out of the money.
• Provisions of certain outstanding warrants could discourage an acquisition of the company by a third party.
• A significant number of the company's shares are eligible for sale and their sale or potential sale may depress the market price of the company's common stock and cause significant dilution to existing stockholders.
• The company's Series B Convertible Preferred Stock includes a liquidation preference.
• The Series B Convertible Preferred Stock includes anti-dilution protection through the date of Stockholder Approval.
• The issuance of common stock upon conversion of the Series B Convertible Preferred Stock and upon exercise of warrants will cause immediate and substantial dilution to existing shareholders.
• The Series B Convertible Preferred Stock includes certain protective provisions and after Stockholder Approval, the Series B Convertible Preferred Stock will vote 40% of the company's then common stock.

Future Outlook

The company plans to launch a B2C online casino operation and explore B2B opportunities, with a target launch date for the first online casino by the end of Q1 2025. The company expects to require significant additional capital to fund its operations and new iGaming venture.

Management Comments

• The Company is currently evaluating all options to monetize its existing assets, in addition to exploring other strategic alternatives to maximize value for its stockholders.
• Potential strategic alternatives that may be explored or evaluated by the Company as part of this process include, but are not limited to, an acquisition, merger, reverse merger, other business combination, sale of assets, licensing or other strategic transactions involving the Company.
• The Company expects to invest a significant amount of capital to fund the development and operation of this business, including but not limited to acquisition or development of a front-end user interface, sourcing of one or more games, acquiring relevant licenses and investing in marketing.
• The Company believes that in the aggregate, it will require significant additional capital funding to complete the commercialization of our back-end blockchain casino assets, including but not limited to acquisition or development of a front-end user interface, sourcing of one or more games, acquiring relevant licenses and investing in marketing, support and expand the research and development and marketing of our products, fund future clinical trials, repay debt obligations, provide capital expenditures for additional equipment and development costs, payment obligations, office space and systems for managing the business, and cover other operating costs until our planned revenue streams from products are fully-implemented and begin to offset our operating costs, if ever.

Industry Context

The company's strategic shift into the iGaming industry reflects a broader trend of companies seeking growth opportunities in the rapidly expanding online gaming market, particularly with the integration of blockchain technology. The company is attempting to leverage its Nasdaq listing to become a consolidator in the iGaming industry.

Comparison to Industry Standards

• The company's move into iGaming is a significant departure from its previous focus on biotechnology, making direct comparisons to industry standards difficult.
• The company's financial performance in Q3 2024 shows a significant reduction in losses compared to Q3 2023, but it still faces challenges in achieving profitability.
• The company's research and development spending is significantly lower than many other biotechnology companies, reflecting its resource constraints and strategic shift.
• The company's acquisition of iGaming assets is a unique move, and its success will depend on its ability to execute its business plan in a competitive market.
• The company's reliance on external funding is similar to many early-stage biotechnology and technology companies, but its need for capital is particularly acute given its lack of revenue and new venture into iGaming.
• The company's compliance issues with Nasdaq are not uncommon for smaller companies, but the mandatory panel monitor adds an additional layer of risk.

Management Changes

Corporate Governance

Legal Proceedings

• The company is involved in ongoing litigation with Dr. Marlene Krauss, Tyche Capital LLC, Ronald Bauer and Samantha Bauer, and AmTrust International Underwriters DAC.
• The company has settled its litigation with Tyche Capital LLC and Ronald Bauer & Samantha Bauer.
• The company received $2.27 million from AmTrust in reimbursement of fees, of which the company received $1.5 million after the payment of attorneys fees.
• The company received an additional $300,140 from AmTrust in reimbursement of fees, of which the company received $200,093 after the payment of attorneys fees.
• The company received $125,000 from Freedom in reimbursement of fees, of which the company received approximately $83,333 after the payment of legal fees.
• The company received a further $125,000 from Freedom in reimbursement of fees, of which the company received $76,639 after the payment of attorneys fees.

Related Party Transactions

• Accounts payable to related parties were $580,830 as of September 30, 2024.
• Research and development expenses to related parties were $151,138 for the three months ended September 30, 2024, and $455,345 for the nine months ended September 30, 2024.

Stakeholder Impact

• Shareholders face the risk of dilution from future equity offerings and the conversion of preferred stock and warrants.
• Employees may be affected by the company's strategic shift and potential restructuring.
• Customers of the planned online casino will be impacted by the company's ability to provide a secure and reliable gaming platform.
• Suppliers and creditors may be affected by the company's financial challenges and potential need to restructure its obligations.
• The company's strategic shift to iGaming may impact its relationships with existing partners and collaborators in the biotechnology sector.

Next Steps

• The company plans to complete the technology transfer of the iGaming assets.
• The company plans to develop and enhance a comprehensive business strategy for the iGaming sector.
• The company plans to complete a full technology development review of the iGaming platform.
• The company plans to begin front-end development for the online casino.
• The company plans to evaluate potential gaming solutions.
• The company plans to evaluate licensing regimes and secure a license.
• The company plans to develop a marketing plan.
• The company plans to assemble a growth team.
• The company plans to integrate and test all components of the casino.
• The company plans to launch the online casino to the public by the end of Q1 2025.

Key Dates

Keywords

iGaming, online casino, blockchain, biotechnology, research and development, financial results, Nasdaq, licensing, capital raise, clinical trials